when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

GLAUKOS Corp ($GKOS) · pipeline · pharmadog

← back to GLAUKOS Corp

Pipeline · $GKOS

13 products

Marketedriboflavin 5'-phosphate sodiumPhotrexa Viscous (riboflavin 5'-phosphate sodium)Keratoconus Phase 3travoprost ERtravoprostOcular Hypertension Phase 2GLK-221Keratoconus Phase 2GLK-302pilocarpinePresbyopia Phase 2GLK-321Demodex Blepharitis Phase 2GLK-401Age Related Macular Degeneration Phase 2IVMED-80Keratoconus Phase 2iLution travoprosttravoprostOcular Hypertension Phase 2pilocarpineKeratoconjunctivitis Sicca (Dry Eye)PreclinicaliDose Next GenerationGlaucoma Preclinicaltriamcinolone acetonide SRtriamcinolone acetonide [INN]Diabetic Macular Edema EPIOXA HD/EPIOXA KITEPIOXA HD/EPIOXA KIT (RIBOFLAVIN 5'-PHOSPHATE SODIUM)keratoconus IDOSE TRIDOSE TR (TRAVOPROST)1 INDICATIONS AND USAGE iDose ® TR (travoprost intracameral implant) is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). iDose ® TR is a prostaglandin analog indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT) ( 1 )